Investment Research Radio interviews the most compelling emerging companies across the public and private markets... from seed stage ventures through TSXV and Nasdaq listed companies. Sector agnostic by design, the show focuses on innovative businesses, disruptive technologies and the major trends shaping industries and markets around the world.
In this episode of Investment Research Radio, Ray Crowley speaks with John Sanwo, Founder and CEO of WearableDose, about the company's development of precision radiation detection technology.
WearableDose is developing wearable radiation sensing technology designed to support radiation monitoring and safety across applications such as healthcare, oncology, defense, aerospace and other environments where radiation exposure is a concern.
Ray and John discuss the technology behind WearableDose, the challenges of developing wearable radiation detection systems, potential applications across different industries, and the company's journey toward commercialization.
The conversation explores the growing role of advanced sensing technologies in improving radiation awareness, monitoring and safety for people working in environments where exposure matters.
Tune in to learn more about WearableDose, its technology and John's vision for the future of wearable radiation detection.
https://wearabledose.com/
13 Oct 2026
NeuroDyne with CEO Dr. Mark Myers
NeuroDyne with CEO Dr. Mark Myers | Investment Research Radio
In this episode of Investment Research Radio, Ray Crowley speaks with Dr. Mark Myers, CEO and CTO of NeuroDyne, about the company's work in wearable electroencephalography (EEG) technology and its development of a wearable EEG cap designed to measure brain activity.
Dr. Myers discusses the technology behind NeuroDyne's approach, its potential applications in neurological monitoring and healthcare, and the company's progress toward FDA Class II clearance.
We explore the challenges of bringing innovative neurotechnology to market, the potential for future product iterations and applications, and the opportunities for wearable brain monitoring as neuroscience and medical technology continue to advance.
Tune in to learn more about NeuroDyne's technology, its development journey, and Dr. Myers' vision for the future of wearable EEG.
https://www.neurodyneinc.com/
8 Oct 2026
D&P Bioinnovations With CEO Dr. Derek Dashti
Derek Dashti, Founder of D&P Bioinnovations | Rebuilding Damaged Tissue From Within
In this episode of Investment Research Radio, I speak with Derek Dashti, founder of D&P Bioinnovations, about a potentially transformative approach to regenerative medicine.
D&P Bioinnovations is developing an implantable, bioresorbable medical technology designed to help the body regenerate damaged tissue rather than simply repair or replace it. The company's approach combines engineered biomaterials with biological signals derived from stem cells to create an environment that can encourage the body's own cells to rebuild damaged tissue.
The company's initial focus is one of the most difficult areas of tissue repair: the esophagus. Severe damage caused by conditions such as cancer can require highly invasive reconstructive procedures, sometimes involving the use of another part of the patient's body to replace the damaged esophagus. D&P's approach is aimed at something fundamentally different: using a temporary implant to support the body's own regenerative processes and potentially restore the tissue from within.
What makes the science so interesting is the possibility that the technology could extend beyond a single organ or disease. If the underlying regenerative approach can be successfully translated into human therapies, it could have applications across a range of damaged tissues.
Derek and I discuss the science behind the technology, what led him to pursue regenerative medicine, the challenges of moving from laboratory research toward clinical applications, and where he believes this technology could ultimately lead.
A fascinating conversation about regenerative medicine, biotechnology, entrepreneurship, and the possibility of changing how damaged human tissue is treated.
dpbioinnovations.com
Podcast Authority Score: 29 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
59
Social presence
0
YouTube
0
Engagement
0
Contact Investment Research Radio
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Investment Research Radio?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
